COVID 19 / CURRENT INFORMATION
COVID - 19
We provide for maximum protection of our employees, with the aim of supplying our products to the healthcare institutions and citizens.
READ MORE
BOSNALIJEK / ABOUT US
Leading Pharmaceutical Company in Bosnia and Herzegovina
We are dedicated to the development of preventive action, palliation and cures and to improving the quality of life.
READ MORE
QUALITY, SAFETY AND EFFICACY
Continuously committed to the needs of our customers
We are committed to the continuous and consistent application of quality standards in all aspects of our business operations and processes.
READ MORE
CAREER / EDUCATION AND DEVELOPMENT
Our employees make our business successful
We devote special attention to talent management, career development and succession planning for key organisational positions.
READ MORE
BOSNALIJEK / SOS CHILDREN’S VILLAGES
We invest in our children’s healthy and carefree living
The second generation of children is being raised in an SOS children’s village family supported by Bosnalijek.
READ MORE
Products
We are continuously committed to our customers and pay special attention to monitoring and analysing their needs
MORE
Investors
We are committed to meeting the expectations of our customers, shareholders and employees
MORE
Products
We are continuously committed to our customers and pay special attention to monitoring and analysing their needs
MORE
Career
Join our family and make your contribution to improving the health of people around the world
MORE
PRESS CENTRE / CORPORATE MOVIE
New corporate movie – Health comes first!
Bosnalijek is known as a manufacturer of highest-quality medications. The company’s quality assurance system is fully in line with national and international rules and standards of good manufacturing practice, meeting the expectations and justifying the trust of our customers, partners, and regulatory institutions. Modernizing our facilities, always advancing our knowledge, and improving our working conditions are the key to our growth. By creating new jobs, investing in knowledge, talent, and young people, and supporting the local community, we are asserting our role as a leader in positive social processes both in the country and abroad. Our vision is to boldly step into new areas and technologies and directly set trends in the pharmaceutical industry, always bearing in mind the highest value — health comes first. Health comes first!
PRESS CENTRE/NEWS
Record semi-annual performance of Bosnalijek in 2022
In the first half of 2022, Bosnalijek, the largest pharmaceutical company in Bosnia and Herzegovina, made record profit before tax of BAM 20.7 million, an increase by BAM 18.9 million compared to the same period of the previous year. The profit is the result of the successfully implemented strategy and activities of the management and employees of Bosnalijek.
In detail
NOTICE
NOTICE OF CONVENING ANNUAL REGULAR ASSEMBLY OF BOSNALIJEK JSC
Pursuant to Article 48 paragraph (1) and (3) of Bosnalijek JSC Statute (consolidated text No: 2830/2017 of 18.09.2017) and Article 230 paragraph (1) of Company Law (Official Gazette of FB&H, No 81/15 and 75/21) and based on the Supervisory Board's Decision on Convening Annual Regular Assembly No: 3700/22 of 15 August 2022 we hereby announce:
In detail
NOTICE
Notice on re-convening Regular Annual Shareholders Assembly of Bosnalijek JSC
Pursuant to Article 55 paragraph (2) and (3) of Statute of Bosnalijek JCS (consolidated text No: 2830/2017 of 18.09.2017) and Article 233 paragraph (1) and (2) of Law on Companies (Official Gazette of Federation of BH No. 81/15 and 75/21), and based on the Supervisory Board's Decision No: 2448/22 of 2 July 2022, we hereby announce:
In detail
novembar 26. 2022 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%